Stay updated on Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays a Locations section with sites in Massachusetts, Missouri, and New York, and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.5%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, indicating a minor version change with no impact on study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page header revision has been updated from v3.2.0 to v3.3.1, with no other content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedRemoval of the general government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange DetectedNo additions or deletions were detected on the Study Details page, and the page content remains focused on the study details.SummaryDifference0.5%

- Check99 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

Stay in the know with updates to Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.